[[Bromocriptine]] can restore fertility. Continued therapy during [[pregnancy]] is associated with a 3.3% [[incidence]] of congenital anomalies and 11% spontaneous [[abortion]] rate which is the same as for the general population. [[Estrogen]] elevation during [[pregnancy]] stimulates hyperplasia of lactotrophs and some [[prolactinoma]]s, but the risk of symptomatic enlargement of [[microadenoma]]s and totally intrasellar [[macroadenoma]]s is <3%, vs. 30% risk for macroadenomas
((Molitch ME. Pregnancy and the hyperprolactinemic woman. N Engl JMed. 1985; 312:1364–1370)).